New managing director at Rinicare



Dr Anthony Holmes

Manchester based digital health company Rinicare has appointed a new managing director.

Dr Anthony Holmes has taken up the post having worked with Rinicare in a consultancy role over the past few months.

Holmes’ career spans both medical and technology sectors, having gained experience working with several machine learning and computer vision firms in the digital entertainment, industrial inspection, and healthcare industries.

Most recently, Holmes has been working with UK-based SMEs to help commercialise AI-based software solutions that have a particular focus on medical applications.

Holmes said: “The reality is that there is a number of exciting innovations in the medtech space. What will set them apart is their ability to work within existing clinical pathways and provide genuine clinical value in a cost-saving manner.

“This is what differentiates Rinicare and is why I was keen to join the team and why Mercia Asset Management and Catapult Ventures support the business. The technology is innovative and cutting edge. But what is exciting about Rinicare, and what sets them apart from the competition, is the fact that the technology has been developed by clinicians for clinicians.

Holmes’ initial priority will be to oversee the first trial deployment of its new clinical platform Stability UO in a large NHS hospital in Greater Manchester later this year.

Stability UO is designed for use in a critical care setting and helps the clinical team identify patients at increased risk of low urine output, a strong risk factor for Acute Kidney Injury

Holmes added: “Rinicare has an innovative portfolio and high-value pipeline of AI-powered solutions that identify patients at high risk of deterioration in different settings, from ICUs to care homes.

“Research has shown that an earlier clinical response offers significant patient benefit as it reduces avoidable harm and enables cost savings to be made by the healthcare system.

“Rinicare’s solutions are designed to strengthen clinical pathways that can have an impact on patient outcomes, whilst being mindful of the economic pressure global healthcare systems are currently facing.

“That is a powerful combination and one which has motivated great interest amongst the healthcare providers we are currently working with.”

1 Comment

Trending stories

Exit mobile version